Zobrazeno 31 - 40
of 475
pro vyhledávání: '"Hisashi Sakamaki"'
Autor:
Tadashi Murase, Kaichi Nishiwaki, Hisashi Sakamaki, Naoki Takezako, Kosei Matsue, Junichi Sakamoto, Chiaki Nakaseko, Satoshi Morita, Kazuteru Ohashi, Yasuji Kouzai, Hina Takano, Takashi Kumagai, Hisashi Wakita, Shimousa Hematology Study Groups Kanto Cml, Chikashi Yoshida, Koiti Inokuchi
Publikováno v:
Cancer Science
This study presents the final report of the multicenter, prospective tyrosine kinase inhibitor discontinuation study, D‐STOP, after a 3‐year follow‐up of 54 patients with chronic CML who discontinued dasatinib after a sustained deep molecular r
Autor:
Kazuko Shibuya, Akira Shibuya, Hisashi Sakamaki, Kazuteru Ohashi, Yuki Goshima, Shinji Nakaoka
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228508 (2020)
PLoS ONE
PLoS ONE
DNAM-1 (CD226) is an activating immunoreceptor expressed on T cells and NK cells and involved in the pathogenesis of acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We previously reported
Autor:
Aiko Igarashi, Kota Yoshifuji, Takeshi Kobayashi, Hideharu Muto, Shuichi Shirane, Hisashi Sakamaki, Tatsuya Konishi, Satoshi Kaito, Shuhei Kurosawa, Naoki Matsuyama, Yuya Kishida, Yuta Yamada, Akihito Nagata, Noriko Doki, Kazuteru Ohashi, Yuho Najima, Takashi Toya, Kyoko Inamoto, Tomoyuki Uchida, Kazuhiko Kakihana
Publikováno v:
Leukemia & Lymphoma. 59:3006-3009
The World Health Organization (WHO) has categorized acute undifferentiated leukemia (AUL) as a rare subtype of acute leukemias of ambiguous lineage (ALAL). The prognosis of AUL is considered poor a...
Publikováno v:
Hepatology Research. 48:469-478
Aim Patients with resolved hepatitis B virus (HBV) infection following hematopoietic stem cell transplantation (HSCT) are potentially at high risk of HBV reactivation. Although antiviral drug therapy is recommended when HBV DNA reappears in the serum
Autor:
Junichi Sakamoto, Noriyoshi Iriyama, Satoshi Hashino, Satoshi Morita, Kazuteru Ohashi, Hina Takano, Shinya Kimura, Hisashi Sakamaki, Koiti Inokuchi, Chiaki Nakaseko, Masayuki Hino, Michihiro Uchiyama
Publikováno v:
Internal Medicine
Objective The aim of this study was to prospectively investigate the efficacy and safety profiles of low-dose dasatinib therapy (50 mg once daily). Methods Patients with chronic myeloid leukemia in the chronic phase (CML-CP) who were being treated wi
Autor:
Aiko Igarashi, Tatsuya Konishi, Satoshi Kaito, Shuichi Shirane, Hisashi Sakamaki, Yuta Yamada, Akihito Nagata, Yuho Najima, Yuya Kishida, Shuhei Kurosawa, Takashi Toya, Noriko Doki, Kota Yoshifuji, Kazuteru Ohashi, Tomoyuki Uchida, Kazuhiko Kakihana, Takeshi Kobayashi, Kyoko Inamoto
Publikováno v:
Annals of Hematology. 98:1799-1801
Autor:
Takashi Toya, Hiroshi Handa, Hiroaki Shimizu, Satoru Takada, Hisashi Sakamaki, Takeshi Kobayashi, Junichi Mukae, Yuho Najima, Nahoko Hatsumi, Yoshiki Okuyama, Naoki Shingai, Noriko Doki, Kazuteru Ohashi, Kyoko Haraguchi
Publikováno v:
Blood. 138:3380-3380
Background: Additional cytogenetic abnormalities (ACA), the most frequent form of cytogenetic changes, are considered as a result of genetic instability and clonal evolution of leukemia cells. Recently, we described that ACA at the first relapse was
Autor:
Masahiro Sakaguchi, Takashi Toya, Shunichiro Yasuda, Hiroaki Shimizu, Shuhei Kurosawa, Tatsuya Konishi, Kyoko Inamoto, Noriko Doki, Kazuteru Ohashi, Hisashi Sakamaki, Kaito Harada, Kazuhiko Kakihana, Toshiaki Takezaki, Akihito Nagata, Naoki Shingai, Yuta Yamada, Kosuke Yoshioka, Junichi Mukae, Yuho Najima, Norihiko Kawamata, Aiko Igarashi, Satoshi Kaito, Takeshi Kobayashi
Publikováno v:
Leukemia Research. 108:106627
Although the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) as a treatment for T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) and Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-A
Autor:
Shigeki Ohtake, Takahisa Yamane, Chiaki Nakaseko, Koichi Miyamura, Kazuteru Ohashi, Shuichi Miyawaki, Atsushi Fujieda, Hisashi Sakamaki, Ryuzo Ohno, Kaito Harada, Hirokazu Okumura, Tomoki Naoe, Yasushi Miyazaki, Noriko Usui, Noriko Doki, Hiroyuki Fujita, Hitoshi Kiyoi, Kazunori Ohnishi, Takeshi Hagino, Tadashi Nagai
Publikováno v:
Annals of Hematology. 97:73-81
Recent studies have described various impacts of obesity and being overweight on acute myeloid leukemia (AML) outcomes in adult patients, but little is known about the impact of being underweight. We compared the outcomes of underweight patients to t
Autor:
Kosei Matsue, Chikashi Yoshida, Kaichi Nishiwaki, Naoki Takezako, Hisashi Sakamaki, Tadashi Murase, Takashi Kumagai, Satoshi Morita, Kazuteru Ohashi, Yasuji Kouzai, Shimousa Hematology Study Groups, Hisashi Wakita, Koiti Inokuchi, Hina Takano, Chiaki Nakaseko, Junichi Sakamoto
Publikováno v:
Cancer Science
Tyrosine kinase inhibitors (TKIs) improve the prognosis of patients with chronic myelogenous leukemia (CML) by inducing substantial deep molecular responses (DMRs); some patients could successfully discontinue TKI therapy after maintaining DMR for